FIRMQUARRYResearch workspace

GOVERNMENT CONTRACT / PURCHASE ORDER

24-002830 THE LABORATORY OF MYELOID MALIGNANCIES REQUIRES THIS PANEL OF ANTIBODIES IN ORDER TO PERFORM SINGLE-CELL GENOMICS AND PROTEOMICS ON BONE MARROW SAMPLES FROM HEALTHY DONOR

Awarded to BIOLEGEND, INC.

PIID 75N92024P00032US · USAspendingResearch & Science
$25K
Data last updated Oct 22, 2026 · Source: USAspending
Transaction obligation$24,970sum disclosed on award record
Current contract valueNot reportednot interchangeable with obligation
Potential contract valueNot reportedincluding options if reported
Award dateDec 1, 2023
Company legal name
BIOLEGEND, INC.
UEI / CAGE
WVJUG294HEM6 / Not reported
Parent award
Not reported
Awarding agency
Department of Health and Human Services
Subagency
National Institutes of Health
Industry
Research & Science
NAICS
325414
PSC
6505
Performance period
Not reported — Not reported
Recipient address
8999 BIOLEGEND WAY, SAN DIEGO, SAN DIEGO, CA, 92121
Place of performance
SAN DIEGO, SAN DIEGO, CA, 92121
Source last modified
Nov 2, 2026

Description

24-002830 THE LABORATORY OF MYELOID MALIGNANCIES REQUIRES THIS PANEL OF ANTIBODIES IN ORDER TO PERFORM SINGLE-CELL GENOMICS AND PROTEOMICS ON BONE MARROW SAMPLES FROM HEALTHY DONORS AND LEUKEMIA PATIENTS.

View federal source ↗

Derived from official transactions

Contract lifecycle

  1. Award announced

    24-002830 THE LABORATORY OF MYELOID MALIGNANCIES REQUIRES THIS PANEL OF ANTIBODIES IN ORDER TO PERFORM SINGLE-CELL GENOMICS AND PROTEOMICS ON BONE MARROW SAMPLES FROM HEALTHY DONOR

    US · usaspendingSource ↗

Point-in-time model

Contract change outlook

Predictive intelligenceInsufficient historyNo eligible point-in-time model has produced a prediction for this record.

Uncollapsed source history

Transactions and modifications

Action dateModificationAction typeExact obligationCurrent totalPotential totalDescriptionSource
Dec 1, 20230Not reported$24,970.00Not reportedNot reported24-002830 THE LABORATORY OF MYELOID MALIGNANCIES REQUIRES THIS PANEL OF ANTIBODIES IN ORDER TO PERFORM SINGLE-CELL GENOMICS AND PROTEOMICS ON BONE MARROW SAMPLES FROM HEALTHY DONORS AND LEUKEMIA PATIENTS.USAspending ↗